2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
16
Breast
16
Thoracic
9
Genitourinary
8
Other hematologic neoplasm
3
Lymphoid
3
Head & Neck
3
CNS
3
Plasma cell
1
Other
1
Gynecologic
1
Endocrine
1
Dermatologic
1
Conditions
Leukemia, Myeloid, Acute
3510
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2499
Leukemia
2362
Leukemia, Lymphocytic, Chronic, B-Cell
1992
Myelodysplastic Syndromes
1412
Hematologic Neoplasms
1385
Lymphoma
1176
Lymphoma, Non-Hodgkin
1079
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
863
Lymphoma, Follicular
761
Multiple Myeloma
739
Lymphoma, Mantle-Cell
730
Lymphoma, Large B-Cell, Diffuse
714
Burkitt Lymphoma
692
Lymphoma, B-Cell, Marginal Zone
645
Hodgkin Disease
636
Recurrence
627
Leukemia, Myelomonocytic, Chronic
536
Neoplasms
519
Lymphoma, Large-Cell, Immunoblastic
451
Myeloproliferative Disorders
445
Leukemia, Myeloid, Chronic-Phase
437
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
414
Congenital Abnormalities
411
Waldenstrom Macroglobulinemia
360
Blast Crisis
353
Leukemia, Myeloid, Accelerated Phase
318
Lymphoma, T-Cell, Cutaneous
311
Primary Myelofibrosis
297
Neoplasms, Plasma Cell
276
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Communication
×
Other hematologic neoplasm
×
Clear all
NCT05335369
2026-05-11
UR-GOAL 2
University of Rochester
Phase NA
Completed
161 enrolled
19 charts
NCT06102330
2025-08-03
HomeVENT
Johns Hopkins University
Phase NA
Recruiting
600 enrolled
NCT06376188
2024-04-19
SimCom
Medical University of Vienna
Phase NA
Completed
46 enrolled